Serum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease

Molecular and Cellular Proteomics

Volumn 11, Issue 8, 2012, Pages 435-452

  Wen, Jian Jun ^a   Zago, M Paola ^b   Nuñez, Sonia ^c   Gupta, Shivali ^a   Burgos, Federico Nuñez ^c   Garg, Nisha Jain ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

^c Hospital San Bernardo ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; BIOLOGICAL MARKER; IMMUNOGLOBULIN Y; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN 11; MYOSIN LIGHT CHAIN 2; PLASMINOGEN; PROSTAGLANDIN; PROTEOME; PROTHROMBIN; UNCLASSIFIED DRUG; VINCULIN;

ACUTE PHASE RESPONSE; ADULT; AFFINITY CHROMATOGRAPHY; AGED; ANGIOGENESIS; ARTICLE; BLOOD VESSEL PERMEABILITY; CARDIOMYOPATHY; CELL MIGRATION; CHAGAS DISEASE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; HEART DISEASE; HEART MUSCLE INJURY; HUMAN; LIPID METABOLISM; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; THROMBOCYTE AGGREGATION; THROMBOSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VASODILATATION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CHAGAS CARDIOMYOPATHY; CHAGAS DISEASE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN CARBONYLATION; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; YOUNG ADULT;

TRYPANOSOMA CRUZI;

EID: 84864801156     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.017640     Document Type: Article

References (81)

1. Chagas disease: A neglected emergency. (2009) Lancet 373, 1820
2. World Health Organization (2010) Chagas disease: Control and elimination. UNDP/World Bank/WHO, http://apps.who.int/gb/ebwha/pdf-files/WHA63/A63-17-en.pdf
3. Bern, C., and Montgomery, S. P. (2009) An estimate of the burden of Chagas disease in the United States. Clin. Infect. Dis. 49, e52-e54
4. World Health Organization (2006) Report of the scientific working group on Chagas disease. UNDP/World Bank/WHO, http://www.who.int/ tdr/diseases/chagas/ swg-chagas.pdf
5. Marin-Neto, J. A., Cunha-Neto, E., Maciel, B. C., and Simões, M. V. (2007) Pathogenesis of chronic Chagas heart disease. Circulation 115, 1109-1123
6. Saravia, S. G., Haberland, A., Bartel, S., Araujo, R., Valda, G., Reynaga, D. D., Ramirez, I. D., Borges, A. C., Wallukat, G., and Schimke, I. (2011) Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas disease. Arch. Pathol. Lab. Med. 135, 243-248
7. Sabatine, M. S., McCabe, C. H., Morrow, D. A., Giugliano, R. P., de Lemos, J. A., Cohen, M., Antman, E. M., and Braunwald, E. (2002) Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. Am. Heart J. 143, 966-970
8. Stanley, B. A., Gundry, R. L., Cotter, R. J., and Van Eyk, J. E. (2004) Heart disease, clinical proteomics and mass spectrometry. Dis. Markers 20, 167-178
9. Rassi, A., Jr., Rassi, A., Little, W. C., Xavier, S. S., Rassi, S. G., Rassi, A. G., Rassi, G. G., Hasslocher-Moreno, A., Sousa, A. S., and Scanavacca, M. I. (2006) Development and validation of a risk score for predicting death in Chagas' heart disease. N. Engl. J. Med. 355, 799-808
10. Rassi, A., Jr., Rassi, A., and Marin-Neto, J. A. (2010) Chagas disease. Lancet 375, 1388-1402
11. Wen, J. J., Vyatkina, G., and Garg, N. (2004) Oxidative damage during chagasic cardiomyopathy development: Role of mitochondrial oxidant release and inefficient antioxidant defense. Free Radic. Biol. Med. 37, 1821-1833
12. Wen, J. J., Dhiman, M., Whorton, E. B., and Garg, N. J. (2008) Tissuespecific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice. Microbes Infect. 10, 1201-1209
13. Wen, J. J., and Garg, N. J. (2008) Mitochondrial generation of reactive oxygen species is enhanced at the Qo site of the complex III in the myocardium of Trypanosoma cruzi-infected mice: Beneficial effects of an antioxidant. J. Bioenerg. Biomembr. 40, 587-598
14. Wen, J. J., and Garg, N. J. (2010) Mitochondrial complex III defects contribute to inefficient respiration and ATP synthesis in the myocardium of Trypanosoma cruzi-infected mice. Antioxid. Redox. Signal. 12, 27-37
15. Wen, J. J., Bhatia, V., Popov, V. L., and Garg, N. J. (2006) Phenyl-α-tertbutyl nitrone reverses mitochondrial decay in acute Chagas disease. Am. J. Pathol. 169, 1953-1964
16. Wen, J. J., Gupta, S., Guan, Z., Dhiman, M., Condon, D., Lui, C., and Garg, N. J. (2010) Phenyl-α-tert-butyl-nitrone and benzonidazole treatment controlled the mitochondrial oxidative stress and evolution of cardiomyopathy in chronic chagasic rats. J. Am. Coll. Cardiol. 55, 2499-2508
17. Stein, R. C., and Zvelebil, M. J. (2002) The application of 2D gel-based proteomics methods to the study of breast cancer. J Mammary Gland Biol. Neoplasia 7, 385-393
18. Van den Bergh, G., and Arckens, L. (2005) Recent advances in 2D electrophoresis: An array of possibilities. Expert Rev. Proteomics 2, 243-252
19. Imai, K., Koshiyama, A., and Nakata, K. (2011) Towards clinical proteomics analysis. Biomed. Chromatogr. 25, 59-64
20. Levreri, I., Musante, L., Petretto, A., Bruschi, M., Candiano, G., and Melioli, G. (2005) Separation of human serum proteins using the Beckman- Coulter PF2D system: Analysis of ion exchange-based first dimension chromatography. Clin. Chem. Lab. Med. 43, 1327-1333
21. Shin, Y. K., Lee, H. J., Lee, J. S., and Paik, Y. K. (2006) Proteomic analysis of mammalian basic proteins by liquid-based two-dimensional column chromatography. Proteomics. 6, 1143-1150
22. Deford, J. H., Nuss, J. E., Amaning, J., English, R. D., Tjernlund, D., and Papaconstantinou, J. (2009) High-throughput liquid-liquid fractionation of multiple protein post-translational modifications. J. Proteome Res. 8, 907-916
23. The Criteria Committee of the New York Heart Association (1994) Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels, 9th Ed., pp. 253-256, Little, Brown & Co., Boston, MA
24. Dhiman, M., Estrada-Franco, J. G., Pando, J. M., Ramirez-Aguilar, F. J., Spratt, H., Vazquez-Corzo, S., Perez-Molina, G., Gallegos-Sandoval, R., Moreno, R., and Garg, N. J. (2009) Increased myeloperoxidase activity and protein nitration are indicators of inflammation in chagasic patients. Clin. Vaccine Immunol. 16, 660-666
25. Dhiman, M., Nakayasu, E. S., Madaiah, Y. H., Reynolds, B. K., Wen, J. J., Almeida, I. C., and Garg, N. J. (2008) Enhanced nitrosative stress during Trypanosoma cruzi infection causes nitrotyrosine modification of host proteins: Implications in Chagas' disease. Am. J. Pathol. 173, 728-740
26. Berger, F., De Meulder, B., Gaigneaux, A., Depiereux, S., Bareke, E., Pierre, M., De, Hertogh, B., Delorenzi, M., and Depiereux, E. (2010) Functional analysis: Evaluation of response intensities: Tailoring ANOVA for lists of expression subsets. BMC Bioinformatics 11, 510
27. Levine, R. L., Garland, D., Oliver, C. N., Amici, A., Climent, I., Lenz, A. G., Ahn, B. W., Shaltiel, S., and Stadtman, E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-478
28. Wen, J. J., and Garg, N. (2004) Oxidative modifications of mitochondrial respiratory complexes in response to the stress of Trypanosoma cruzi infection. Free Radic. Biol. Med. 37, 2072-2081
29. Yu, H. L., Chertkow, H. M., Bergman, H., and Schipper, H. M. (2003) Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma. Proteomics 3, 2240-2248
30. Bouwman, F. G., de Roos, B., Rubio-Aliaga, I., Crosley, L. K., Duthie, S. J., Mayer, C., Horgan, G., Polley, A. C., Heim, C., Coort, S. L., Evelo, C. T., Mulholland, F., Johnson, I. T., Elliott, R. M., Daniel, H., and Mariman, E. C. (2011) 2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fasting. BMC Med. Genomics 4, 24
31. Hu, S., Loo, J. A., and Wong, D. T. (2006) Human body fluid proteome analysis. Proteomics 6, 6326-6353
32. Zacks, M. A., Wen, J. J., Vyatkina, G., Bhatia, V., and Garg, N. (2005) An overview of chagasic cardiomyopathy: Pathogenic importance of oxidative stress. An. Acad. Bras. Cienc. 77, 695-715
33. Gupta, S., Wen, J. J., and Garg, N. J. (2009) Oxidative stress in Chagas disease. Interdiscip. Perspect. Infect. Dis. 2009, 190354
34. Rabilloud, T., Chevallet, M., Luche, S., and Lelong, C. (2010) Two-dimensional gel electrophoresis in proteomics: Past, present and future. J. Proteomics 73, 2064-2077
35. Li, X., Xiong, L., Xie, C., Cao, J., Deng, H., Lin, Y., Cao, R., Li, J., Chen, P., and Liang, S. (2010) Proteomics analysis of plasma membrane from liver sinusoidal endothelial cells after partial hepatectomy by an improved two-dimensional electrophoresis. Mol. Cell Biochem. 344, 137-150
36. Suberbielle, E., Gonzalez-Dunia, D., and Pont, F. (2008) High reproducibility of two-dimensional liquid chromatography using pH-driven fractionation with a pressure-resistant electrode. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 871, 125-129
37. Skalnikova, H., Rehulka, P., Chmelik, J., Martinkova, J., Zilvarova, M., Gadher, S. J., and Kovarova, H. (2007) Relative quantitation of proteins fractionated by the ProteomeLab PF 2D system using isobaric tags for relative and absolute quantitation (iTRAQ). Anal. Bioanal. Chem. 389, 1639-1645
38. Abdel-Hafeez, E. H., Kikuchi, M., Watanabe, K., Ito, T., Yu, C., Chen, H., Nara, T., Arakawa, T., Aoki, Y., and Hirayama, K. (2009) Proteome approach for identification of Schistosomiasis japonica vaccine candidate antigen. Parasitol. Int. 58, 36-44
39. Chen, E. I., Hewel, J., Felding-Habermann, B., and Yates, J. R., 3rd. (2006) Large scale protein profiling by combination of protein fractionation and multidimensional protein identification technology (MudPIT). Mol. Cell. Proteomics 5, 53-56
40. Pirondini, A., Visioli, G., Malcevschi, A., and Marmiroli, N. (2006) A 2-D liquid-phase chromatography for proteomic analysis in plant tissues. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 833, 91-100
41. Sheng, S., Chen, D., and Van Eyk, J. E. (2006) Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: Optimization and protein database. Mol. Cell. Proteomics 5, 26-34
42. Kayama, H., and Takeda, K. (2010) The innate immune response to Trypanosoma cruzi infection. Microbes Infect. 12, 511-517
43. Junqueira, C., Caetano, B., Bartholomeu, D. C., Melo, M. B., Ropert, C., Rodrigues, M. M., and Gazzinelli, R. T. (2010) The endless race between Trypanosoma cruzi and host immunity: Lessons for and beyond Chagas disease. Expert Rev. Mol. Med. 12, e29
44. Gupta, S., Bhatia, V., Wen, J. J., Wu, Y., Huang, M. H., and Garg, N. J. (2009) Trypanosoma cruzi infection disturbs mitochondrial membrane potential and ROS production rate in cardiomyocytes. Free Radic. Biol. Med. 47, 1414-1421
45. Ba, X., Gupta, S., Davidson, M., and Garg, N. J. (2010) Trypanosoma cruzi induces ROS-PARP-1-RelA pathway for up-regulation of cytokine expression in cardiomyocytes. J. Biol. Chem. 285, 11596-11606
46. Ribeiro, C. M., Budni, P., Pedrosa, R. C., Farias, M. S., Parisotto, E. B., Dalmarco, E. M., Fröde, T. S., Oliveira-Silva, D., Colepicolo, P., and Filho, D. W. (2010) Antioxidant therapy attenuates oxidative insult caused by benzonidazole in chronic Chagas' heart disease. Int. J. Cardiol. 145, 27-33
47. Souza, A. P., Jelicks, L. A., Tanowitz, H. B., Olivieri, B. P., Medeiros, M. M., Oliveira, G. M., Pires, A. R., Santos, A. M., and Araújo-Jorge, T. C. (2010) The benefits of using selenium in the treatment of Chagas disease: Prevention of right ventricle chamber dilatation and reversion of Trypanosoma cruzi-induced acute and chronic cardiomyopathy in mice. Mem. Inst. Oswaldo Cruz 105, 746-751
48. Ezzell, R. M., Goldmann, W. H., Wang, N., Parashurama, N., and Ingber, D. E. (1997) Vinculin promotes cell spreading by mechanically coupling integrins to the cytoskeleton. Exp. Cell Res. 231, 14-26
49. Guiñazú, N., Carrera-Silva, E. A., Becerra, M. C., Pellegrini, A., Albesa, I., and Gea, S. (2010) Induction of NADPH oxidase activity and reactive oxygen species production by a single Trypanosoma cruzi antigen. Int. J. Parasitol. 40, 1531-1538
50. Smyth, E. M., Grosser, T., Wang, M., Yu, Y., and FitzGerald, G. A. (2009) Prostanoids in health and disease. J. Lipid Res. 50, (suppl.) S423-S428
51. Tanowitz, H. B., Burns, E. R., Sinha, A. K., Kahn, N. N., Morris, S. A., Factor, S. M., Hatcher, V. B., Bilezikian, J. P., Baum, S. G., and Wittner, M. (1990) Enhanced platelet adherence and aggregation in Chagas' disease: A potential pathogenic mechanism for cardiomyopathy. Am. J. Trop. Med. Hyg. 43, 274-281
52. Pinge-Filho, P., Tadokoro, C. E., and Abrahamsohn, I. A. (1999) Prostaglandins mediate suppression of lymphocyte proliferation and cytokine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 193, 90-98
53. Mukherjee, S., Machado, F. S., Huang, H., Oz, H. S., Jelicks, L. A., Prado, C. M., Koba, W., Fine, E. J., Zhao, D., Factor, S. M., Collado, J. E., Weiss, L. M., Tanowitz, H. B., and Ashton, A. W. (2011) Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease. PLoS One 6, e16959
54. Abdalla, G. K., Faria, G. E., Silva, K. T., Castro, E. C., Reis, M. A., and Michelin, M. A. (2008) Trypanosoma cruzi: The role of PGE2 in immune response during the acute phase of experimental infection. Exp. Parasitol. 118, 514-521
55. Schaller, J., and Gerber, S. S. (2011) The plasmin-antiplasmin system: Structural and functional aspects. Cell. Mol. Life Sci. 68, 785-801
56. Franchini, M., and Lippi, G. (2010) Prothrombin complex concentrates: An update. Blood Transfus. 8, 149-154
57. Jankun, J., Keck, R., Selman, S. H., and Skrzypczak-Jankun, E. (2010) Systemic or topical application of plasminogen activator inhibitor with extended half-life (VLHL PAI-1) reduces bleeding time and total blood loss. Int. J. Mol. Med. 26, 501-504
58. Griffin, M. O., Jinno, M., Miles, L. A., and Villarreal, F. J. (2005) Reduction of myocardial infarct size by doxycycline: A role for plasmin inhibition. Mol. Cell. Biochem. 270, 1-11
59. Aso, Y., Wakabayashi, S., Yamamoto, R., Matsutomo, R., Takebayashi, K., and Inukai, T. (2005) Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: Synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor. Diabetes Care 28, 2211-2216
60. Das, R., Pluskota, E., and Plow, E. F. (2010) Plasminogen and its receptors as regulators of cardiovascular inflammatory responses. Trends Cardiovasc. Med. 20, 120-124
61. Sakkinen, P. A., Cushman, M., Psaty, B. M., Rodriguez, B., Boineau, R., Kuller, L. H., and Tracy, R. P. (1999) Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. Arterioscler. Thromb. Vasc. Biol. 19, 499-504
62. Herrera, R. N., Diaz, E., Perez Aguilar, R., Bianchi, J., Berman, S., and Luciardi, H. L. (2005) Prothrombotic state in early stages of chronic Chagas' disease: Its association with thrombotic risk factors. Arch. Cardiol. Mex. 75, (Suppl. 3) S3-38-S3-48
63. Kim, J. H., Yu, Y. S., Min, B. H., and Kim, K. W. (2007) The role of clusterin in retinal development and free radical damage. Br. J. Ophthalmol. 91, 1541-1546
64. Hineno, A., Kaneko, K., Yoshida, K., and Ikeda, S. I. (2011) Ceruloplasmin protects against rotenone-induced oxidative stress and neurotoxicity. Neurochem. Res. 36, 2127-2135
65. Adamsson Eryd, S., Smith, J. G., Melander, O., Hedblad, B., and Engström, G. (2011) Inflammation-sensitive proteins and risk of atrial fibrillation: A population-based cohort study. Eur. J. Epidemiol. 26, 449-455
66. Krishnan, N., Dickman, M. B., and Becker, D. F. (2008) Proline modulates the intracellular redox environment and protects mammalian cells against oxidative stress. Free Radic. Biol. Med. 44, 671-681
67. Gutteridge, J. M. (1986) Antioxidant properties of the proteins caeruloplasmin, albumin and transferrin. A study of their activity in serum and synovial fluid from patients with rheumatoid arthritis. Biochim. Biophys. Acta 869, 119-127
68. Cohen, M. P. (2003) Intervention strategies to prevent pathogenetic effects of glycated albumin. Arch. Biochem. Biophys. 419, 25-30
69. Goldman, R. D., Khuon, S., Chou, Y. H., Opal, P., and Steinert, P. M. (1996) The function of intermediate filaments in cell shape and cytoskeletal integrity. J. Cell Biol. 134, 971-983
70. Faé, K. C., Diefenbach da Silva, D., Bilate, A. M., Tanaka, A. C., Pomerantzeff, P. M., Kiss, M. H., Silva, C. A., Cunha-Neto, E., Kalil, J., and Guilherme, L. (2008) PDIA3, HSPA5 and vimentin, proteins identified by 2-DE in the valvular tissue, are the target antigens of peripheral and heart infiltrating T cells from chronic rheumatic heart disease patients. J. Autoimmun. 31, 136-141
71. Cunha-Neto, E., Dzau, V. J., Allen, P. D., Stamatiou, D., Benvenutti, L., Higuchi, M. L., Koyama, N. S., Silva, J. S., Kalil, J., and Liew, C. C. (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am. J. Pathol. 167, 305-313
72. Richard, P., Charron, P., Carrier, L., Ledeuil, C., Cheav, T., Pichereau, C., Benaiche, A., Isnard, R., Dubourg, O., Burban, M., Gueffet, J. P., Millaire, A., Desnos, M., Schwartz, K., Hainque, B., and Komajda, M. (2003) Hypertrophic cardiomyopathy: Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 107, 2227-2232
73. Poetter, K., Jiang, H., Hassanzadeh, S., Master, S. R., Chang, A., Dalakas, M. C., Rayment, I., Sellers, J. R., Fananapazir, L., and Epstein, N. D. (1996) Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nat. Genet. 13, 63-69
74. Flavigny, J., Richard, P., Isnard, R., Carrier, L., Charron, P., Bonne, G., Forissier, J. F., Desnos, M., Dubourg, O., Komajda, M., Schwartz, K., and Hainque, B. (1998) Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. J. Mol. Med. 76, 208-214
75. Szczesna, D., Ghosh, D., Li, Q., Gomes, A. V., Guzman, G., Arana, C., Zhi, G., Stull, J. T., and Potter, J. D. (2001) Familial hypertrophic cardiomyopathy mutations in the regulatory light chains of myosin affect their structure, Ca2+ binding, and phosphorylation. J. Biol. Chem. 276, 7086-7092
76. Pannu, H., Tran-Fadulu, V., Papke, C. L., Scherer, S., Liu, Y., Presley, C., Guo, D., Estrera, A. L., Safi, H. J., Brasier, A. R., Vick, G. W., Marian, A. J., Raman, C. S., Buja, L. M., and Milewicz, D. M. (2007) MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. Hum. Mol. Genet. 16, 2453-2462
77. Pannu, H., Avidan, N., Tran-Fadulu, V., and Milewicz, D. M. (2006) Genetic basis of thoracic aortic aneurysms and dissections: Potential relevance to abdominal aortic aneurysms. Ann. N.Y. Acad. Sci. 1085, 242-255
78. Milewicz, D. M., Guo, D. C., Tran-Fadulu, V., Lafont, A. L., Papke, C. L., Inamoto, S., Kwartler, C. S., and Pannu, H. (2008) Genetic basis of thoracic aortic aneurysms and dissections: Focus on smooth muscle cell contractile dysfunction. Annu. Rev. Genomics Hum. Genet. 9, 283-302
79. Janssen, M. E., Kim, E., Liu, H., Fujimoto, L. M., Bobkov, A., Volkmann, N., and Hanein, D. (2006) Three-dimensional structure of vinculin bound to actin filaments. Mol. Cell 21, 271-281
80. Zemljic-Harpf, A., Manso, A. M., and Ross, R. S. (2009) Vinculin and talin: Focus on the myocardium. J. Investig. Med. 57, 849-855
81. Dhiman, M., and Garg, N. J. (2011) NADPH oxidase inhibition ameliorates Trypanosoma cruzi-induced myocarditis during Chagas disease. J. Pathol. 225, 583-596.